Nautilus Biotechnology Inc (NAUT)
2.95
+0.03
(+1.03%)
USD |
NASDAQ |
May 17, 16:00
2.95
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Shareholders Equity (Quarterly): 249.49M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 249.49M |
| December 31, 2023 | 265.35M |
| September 30, 2023 | 277.27M |
| June 30, 2023 | 289.67M |
| March 31, 2023 | 303.72M |
| December 31, 2022 | 314.92M |
| September 30, 2022 | 325.34M |
| Date | Value |
|---|---|
| June 30, 2022 | 337.56M |
| March 31, 2022 | 349.71M |
| December 31, 2021 | 363.58M |
| September 30, 2021 | 377.85M |
| June 30, 2021 | 390.04M |
| December 31, 2020 | -29.72M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-29.72M
Minimum
Dec 2020
390.04M
Maximum
Jun 2021
293.44M
Average
314.92M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 130.69M |
| Geron Corp | 344.87M |
| TG Therapeutics Inc | 160.11M |
| Editas Medicine Inc | 294.40M |
| G1 Therapeutics Inc | 27.74M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 288.65M |
| Total Liabilities (Quarterly) | 39.16M |